fda approval status of bpc 157 and tb 500 peptides BPC-157 / TB-500 Blend (Dual Peptide) BPC-157 and TB-500 for Torn
Description
These compounds are classified as NDBs and have unique physical, chemical, and mechanical properties, which are exploited in biomedical applications
They may appear to be similar in structure, but they differ in their tissue interactions
You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch
If you are on a microdosing protocol at 1 mg or 1.25 mg per dose, a 0.3 mL syringe gives you the most accurate draws
